http://orcid.org/0000-0002-4770-8159
References
- Thanigaimani S, Lau DH, Agbaedeng T, et al. Molecular mechanisms of atrial fibrosis: implications for the clinic. Expert Rev Cardiovasc Ther. 2017;15(4):247–256.
- O’Neill L, Harrison J, O’Neill M, et al. Clinical, electrophysiological and imaging predictors of atrial fibrillation ablation outcome. Expert Rev Cardiovasc Ther. 2017;15(4):289–305.
- Gattellari M, Goumas C, Aitken R, et al. Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management). Cerebrovasc Dis. 2011;32(4):370–382.
- Hijazi Z, Oldgren J, Siegbahn A, et al. Application of biomarkers for risk stratification in patients with atrial fibrillation. Clin Chem. 2017;63(1):152–164.
- Ozeke O, Aras S, Baser K, et al. Defensive medicine due to different fears by patients and physicians in geriatric atrial fibrillation patients and second victim syndrome. Int J Cardiol. 2016;212:251–252.
- Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–129.
- Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486.
- Reiffel J, Verma A, Halperin JL, et al. Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am Heart J. 2014;167(1):22–27.
- Van Gelder IC, Healey JS, Crijns H, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38(17):1339–1344.
- Martin DT, Bersohn MM, Waldo AL, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26):1660–1668.
- Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J. 2013;34(35):2731–2738.
- Akoum N. New perspectives on atrial fibrillation and stroke. Heart. 2016;102:1788–1792.
- Srivatsa UN, Rogers J. Sarcoidosis and atrial fibrillation: a rare association and interlink with inflammation. Indian Pacing Electrophysiol J. 2012;12(6):290–291.
- Kamel H, Okin PM, Longstreth WT Jr., et al. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol. 2015;11(3):323–331.
- Laish-Farkash A, Suleiman M. Primary versus secondary atrial fibrillation: is it time for a different classification of atrial fibrillation? J Cardiovasc Electrophysiol. 2015;26(12):1295–1297.
- Ghanbari H, Baser K, Jongnarangsin K, et al. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11(9):1503–1511.
- Bayes de Luna A, Baranchuk A, Martinez-Selles M, et al. Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift? Ann Noninvasive Electrocardiol. 2017;22(1). DOI:10.1111/anec.12417
- Nuhrich JM, Geisler AC, Steven D, et al. Active atrial function and atrial scar burden after multiple catheter ablations of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2017;40(2):175–182.
- Canpolat U, Ozeke O, Cay S, et al. Worsened diastology after radiofrequency catheter ablation in AF patients: more touches more stiff left atrium. Int J Cardiol. 2013;168(5):4801–4802.
- Själander S, Holmqvist F, Smith JG, et al. Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation. JAMA Cardiol. 2017;2(2):146–152.